Targeting cancer stem cells in the clinic: Current status and perspectives

Stephanie Annett1, Tracy Robson1

  • 1Molecular and Cellular Therapeutics, Royal College of Surgeons Ireland, Ireland.

Insights

Cancer stem cells (CSCs) drive treatment resistance and relapse. Targeting CSCs via cell surface receptors and signaling pathways shows promise for new cancer therapies.

Area of Science:

  • Oncology
  • Cancer Biology
  • Translational Medicine

Background:

  • Cancer stem cells (CSCs) are implicated in chemotherapy resistance and tumor relapse, posing significant clinical challenges.
  • CSCs can evade various novel therapeutic strategies, including targeted agents, immunotherapies, and anti-angiogenics.
  • Identifying and isolating CSCs remains a major hurdle in cancer research and treatment development.

Purpose of the Study:

  • To review and evaluate current therapeutic strategies aimed at targeting cancer stem cells (CSCs).
  • To discuss the challenges and advancements in identifying and isolating CSCs for therapeutic development.

Main Methods:

  • Review of existing literature on cancer stem cell biology and therapeutic targeting.
  • Evaluation of pre-clinical and clinical data for agents targeting CSCs.
  • Discussion of novel technologies for CSC identification and isolation.

Main Results:

  • Agents targeting CSC-associated cell surface receptors and signaling pathways have shown promising pre-clinical results.
  • Several CSC-targeting agents are advancing into clinical trials.
  • Novel technologies are being employed to overcome challenges in CSC identification and isolation.

Conclusions:

  • Targeting cancer stem cells is a critical strategy to overcome treatment resistance and prevent cancer relapse.
  • Advancements in CSC identification and therapeutic targeting offer new hope for improved cancer patient outcomes.
  • Further clinical investigation of CSC-targeting agents is warranted.

Related Concept Videos

Changes in Skin Color: Clinical Perspectives01:14

Changes in Skin Color: Clinical Perspectives

The first thing a clinician sees is the skin, so the examination of the skin should be part of any thorough physical examination. Most skin disorders are relatively benign, but a few, including melanomas, can be fatal if untreated. A couple of the more noticeable disorders, albinism and vitiligo, affect the appearance of the skin and its accessory organs.
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...
3.8K
Clinical Applications of Epidermal Stem Cells01:19

Clinical Applications of Epidermal Stem Cells

Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...
3.3K
Distinctive Features of Adult Stem Cells vs Cancer Stem Cells01:18

Distinctive Features of Adult Stem Cells vs Cancer Stem Cells

A stem cell is an unspecialized cell that can divide without limit as needed and can, under specific conditions, differentiate into specialized cells.
Adult stem cells
Adult stem cells are tissue-specific; hence, they divide to develop the tissue from which they originate. One type of adult stem cell is the epithelial stem cell, which gives rise to the keratinocytes in the multiple layers of epithelial cells in the epidermis of the skin. Adult bone marrow has three distinct types of stem cells:...
4.5K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
6.1K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.0K
Adult Stem Cells01:33

Adult Stem Cells

Stem cells are undifferentiated cells that divide and produce more stem cells or progenitor cells that differentiate into mature, specialized cell types. All the cells in the body are generated from stem cells in the early embryo, but small populations of stem cells are also present in many adult tissues including the bone marrow, brain, skin, and gut. These adult stem cells typically produce the various cell types found in that tissue—to replace cells that are damaged or to continuously...
33.9K